𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney

✍ Scribed by Smaragdi Antonopoulou; Constantinos A. Demopoulos; Christos Iatrou; George Moustakas; Panos Zirogiannis

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
483 KB
Volume
26
Category
Article
ISSN
0020-711X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Platelet-activating factor (PAF) acetylh
Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures
✍ Orit Shmueli; Aviv Cahana; Orly Reiner πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

Lissencephaly patients are born with severe brain malformations and suffer from recurrent seizures. LIS1, the gene mutated in isolated lissencephaly patients, is a subunit of the heterotrimeric cytosolic enzyme platelet-activating factor acetylhydrolase (PAF-AH), interacts with tubulin, and affects

Rabbit blastocysts accumulate platelet-a
Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro
✍ M. A. Jones; G. B. Kudolo; M. J. K. Harper πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 915 KB

## Abstract Platelet‐activating factor (1‐__O__‐alkyl‐2‐acetyl‐__sn__‐glycero‐3‐phosphorylcholine; PAF) is a very potent phospholipid, which has been demonstrated to stimulate smooth muscle and change vascular permeability. PAF has been detected in the rabbit preimplantation uterine endometrium and

Activity of platelet-activating factor a
Activity of platelet-activating factor acetylhydrolase exists in red cell membrane
✍ Hidemi Yoshida; Kei Satoh; Dr. Tada-Atsu Imaizumi πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

We have described the intracellular type of platelet-activating factor acetylhydrolase (PAF-AH) in the membrane extract of human red blood cells (RBCs). The enzymatic activity was inhibited by diisopropylfluorophosphate, trypsin or pronase E, but not affected by EDTA or the addition of 1 -0-hexadecy

Heterogeneous nucleation-controlled part
Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation
✍ Eva Y. Chi; Joachim Weickmann; John F. Carpenter; Mark C. Manning; Theodore W. R πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

Clinical lots of recombinant human platelet-activating factor acetylhydrolase (rhPAF-AH) were prepared in a lyophilized formulation. After reconstitution with sterile water for injection to form an aqueous solution (10 mM sodium citrate, 7.5 w/v% sucrose, and 0.1 w/v% Pluronic-F68, pH 6.5), a few vi